Altrova Health Inc (SSPLF) fair value: what the stock is really worth
We calculate from audited financials what Altrova Health Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Aug 22, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch Altrova Health Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Altrova Health Inc. is a venture capital firm specializing in incubation, seed/startups and early venture. It prefers to invest in drug, pharmaceuticals and tightly woven fabric, medtech and AI healthcare Spectrum, diagnostics, treatment, medical technology sectors. Altrova Health Inc. was founded in 2022 and is based in Vancouver, Canada.
Stock analysis
Altrova Health Inc (SSPLF) currently trades at $0.0468, while our model-based Fair Value estimate is $0.0235, 49.8% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 87/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Financial Services sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Altrova Health Inc reported revenue of C$29.5K in FY2025 versus C$0 in FY2023. Reported net income was −C$4.3M in FY2025.
Key figures
Market cap $8.5M · P/S ratio 44.1 · EPS (TTM) $−0.0200 · Return on equity −135% · Return on assets (EBIT) −228% · Operating margin −664% · Free cash flow −C$959K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (medium confidence).
What moves the price
The share trades about 31% below its 52-week high and 368% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −15% fair-value upside, at −50%, SSPLF screens richer than that median.
Fair Value models
Bear $0.0235Fair Value $0.0235Bull $0.0235
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 661 stocks
Beats the industry median on 0/5 measures
Overall it trails its industry peers.
Valuation
Quality Score42 · Bottom 25%
Fair Value upside−49.8% · Bottom 25%
Profitability
Return on assets−26.3% · Bottom 25%
Growth and dividend
Revenue growth0.0% · Below median
Valuation Multiplesvs Asset Management median · lower = cheaper
P/B3.57× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Altrova Health Inc Fair Value". https://www.fairvalue-calculator.com/stock/SSPLF
Frequently asked questions
Is Altrova Health Inc (SSPLF) overvalued or undervalued?
As of Aug 22, 2026, our model estimates a fair value of $0.0235 versus a price of $0.0468, about −50% upside (overvalued).
What is the fair value of SSPLF?
Our model-based fair value for Altrova Health Inc is $0.0235 (as of Aug 22, 2026), built from audited fundamentals. The current price: $0.0468.
What is the quality score of SSPLF?
Altrova Health Inc has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Altrova Health Inc (SSPLF)?
Our model-based price target is the fair value of $0.0235 (as of Aug 22, 2026) from 2 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Altrova Health Inc stock forecast for 2026?
Our models put fair value at $0.0235, about −50% upside versus a price of $0.0468 (overvalued). The calculation is refreshed regularly with new filings.
What is the intrinsic value of Altrova Health Inc (SSPLF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Altrova Health Inc it is $0.0235 per share (as of Aug 22, 2026), against a price of $0.0468. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Altrova Health Inc stock overvalued or undervalued in 2026?
As of Aug 22, 2026, SSPLF trades above its calculated fair value: price $0.0468, fair value $0.0235, a gap of about −50% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SSPLF?
No. The price is what the market pays today ($0.0468); the fair value is what the company's own numbers justify ($0.0235). For Altrova Health Inc the two are $0.0233 per share apart. That gap is exactly why we show both numbers side by side.
How much is Altrova Health Inc worth?
The market values Altrova Health Inc at about $8.5M (market capitalisation, as of Aug 22, 2026). Per share that is $0.0468; our models calculate a fair value of $0.0235 per share.
How solid is the balance sheet of Altrova Health Inc (SSPLF)?
Balance-sheet figures for Altrova Health Inc (as of Aug 22, 2026): return on equity −134.7%. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is SSPLF from its 52-week high?
Altrova Health Inc trades at $0.0468, about 31% below its 52-week high of $0.0680 and 368% above the low of $0.0100 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0235 is for.
Which stocks are comparable to Altrova Health Inc?
From the same area (Financial Services) we also value Blackstone Inc, KKR & Co, Brookfield Corporation, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Altrova Health Inc stock attractive at the current price?
The data as of Aug 22, 2026: price $0.0468, calculated fair value $0.0235 (−50%), Quality Score 38/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SSPLF calculated?
We run Altrova Health Inc through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0235, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Altrova Health Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Altrova Health Inc (SSPLF)?
The closing price on Sep 24, 2026 was $0.0468. Our model-based fair value is $0.0235, about −50% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Altrova Health Inc right now?
The price sits above even our optimistic bull case ($0.0235). The favourable scenario is already priced in. Weak quality (38/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Altrova Health Inc
How large is the market capitalisation of Altrova Health Inc (SSPLF)?
The market capitalisation of Altrova Health Inc is $8.5M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Altrova Health Inc (SSPLF)?
The price-to-sales ratio of Altrova Health Inc is 44.1 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Altrova Health Inc (SSPLF)?
Earnings per share at Altrova Health Inc are $−0.0200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Altrova Health Inc (SSPLF)?
The return on equity (ROE) of Altrova Health Inc is −135% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Altrova Health Inc (SSPLF)?
On an EBIT basis the return on assets of Altrova Health Inc is −228% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Altrova Health Inc (SSPLF)?
The operating margin of Altrova Health Inc is −664% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does Altrova Health Inc (SSPLF) generate?
The free cash flow of Altrova Health Inc is −C$959K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Altrova Health Inc in the live analysis
One click puts Altrova Health Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Aug 22, 2026